- Companies
- Huma.AI
Huma.AI Valuation, Funding & Investors
Huma.AI is valued at $1B as of September 2024.
Last Huma.AI valuation
$1B
Seed · Sep 2024
Last Huma.AI funding round
$1M
Seed · Apr 2025
Cumulative funding Huma.AI raised
$15M
across 4 funding rounds
Key investors in Huma.AI
Fusion Fund
Hatteras Venture Partners
Shangbay Capital
Boston Millennia Partners
Excelerate Health Ventures
SteelSky Ventures
About Huma.AI
Huma.AI is an AI platform tailored for Medical Affairs in life sciences, featuring the Knowledge Hub for Life Sciences as its core product. The hub analyzes data from advisory boards, surveys, internal files, and other repositories to identify themes, generate evidence, track trends, perform comparative analysis, evaluate sentiment, and filter results. Single-tenant security and large language model integration enable real-time insights on competitive landscapes, drug development, regulatory issues, and market trends. Redwood City-based Huma.AI unifies disparate data sources for informed decision-making.
Founded
2018
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Valuation
$1B (Sep 2024)
Huma.AI Valuation
Huma.AI is currently valued at $1B, based on its seed round in September 2024.
Huma.AI valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Sep 2024 | Seed | $1B |
Huma.AI Funding History
Huma.AI has raised a total of $15M across 4 funding rounds.
Huma.AI's first fundraising round was a $2M seed round in October 2019. The most recent completed round was a $1M seed round in April 2025.
Huma.AI funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Apr 2025 | Seed | - | $1M | - | Huma.AI is a business intelligence platform built for the healthcare industry, founded to empower healthcare organizations to make data-driven decisions on drug development, devices, and diagnostics. On April 3, 2025, the company announced a Series A-III funding round of $1.02 million, with participation from Excelerate Health Ventures, Fusion Fund, and Hatteras Venture. No valuation, revenue, or profitability metrics were publicly disclosed for this round. |
| Sep 2024 | Seed | - | $2M | $1B | Huma is a UK-based healthcare technology company that develops the Huma Cloud Platform to enable digital health solutions for care and research, powering projects in over 3,000 hospitals and clinics across more than 70 countries. The platform has engaged and screened over 35 million individuals, with 1.8 million active users, and its U.S. remote patient monitoring product covers 140,000 contracted lives following new reimbursement codes. Huma announced a Series D funding round of $80 million in July 2024, led by investors including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures, and Leaps by Bayer, bringing total funding raised to over $300 million. The round valued the company near $1 billion and will support development of the Huma Cloud Platform and expansion of AI capabilities. Huma reported doubling its revenue year-on-year and targets profitability in the current year. |
| Feb 2022 | Series A | Excelerate Health Ventures (lead); Boston Millennia Partners; Shangbay Capital; Fusion Fund; SteelSky Ventures; Human Longevity and Performance Impact Venture Fund; King Fund; W Fund; Hatteras Venture Partners | $10M | - | Huma.AI raised funding in a Series A round on February 4, 2022, led by Excelerate Health Ventures with participation from investors including Fusion Fund and Hatteras Venture Partners. The exact amount raised and post-money valuation are not specified in available records. |
| Oct 2019 | Seed | Fusion Fund (lead) | $2M | - | - |
Who has invested in Huma.AI?
9 investors have backed Huma.AI across its funding rounds, including Fusion Fund, Hatteras Venture Partners, Shangbay Capital, Boston Millennia Partners, Excelerate Health Ventures and SteelSky Ventures.
Lead investors include Excelerate Health Ventures and Fusion Fund.
Huma.AI Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Oct 2019 | ||
| 1 | Lead | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
This data is available for Pro users. Sign up to see all 9 Huma.AI investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialHuma.AI Competitors
Huma.AI competitors include listed companies like Claritev and Vitec Software, and private ones like Axtria, AgentSync, Wheel and Overjet.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $965M | $466M | $538M | 5.2x | ||
| Private | - | - | $900M | - | ||
| Private | $11M | - | $1.2B | 109.1x | ||
| Private | - | - | $1.2B | - | ||
| Private | - | - | $712M | - | ||
| Publicly listed | $371M | $151M | $1B | 3.5x |
Huma.AI Public Comps
Huma.AI is still privately-owned, but its public comps include iFLYHealth, Vitec Software, PHC Holdings, HealthStream, MedicalSystem Technology, Beijing Join-Cheer, Hangzhou Pinming Software, Sphere, Clarivate and B-Soft Co..
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $136M | ($7M) | 7.7x | 6.2x | (150.8x) | (144172.5x) | |||
| $371M | $151M | 3.7x | 3.5x | 9.1x | 9.0x | |||
| $2.3B | $320M | 1.0x | 1.0x | 7.2x | 6.5x | |||
| $304M | $63M | 2.8x | 2.6x | 13.2x | 11.2x | |||
| $45M | $12M | 18.9x | 15.6x | 70.7x | 62.9x | |||
| $386M | $11M | 1.9x | - | 68.9x | - | |||
| $65M | $8M | 12.5x | 11.9x | 100.2x | - | |||
| $70M | $6M | 14.3x | 6.9x | 156.3x | 103.0x | |||
This data is available for Pro users. Sign up to see all Huma.AI competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Huma.AI
| When was Huma.AI founded? | Huma.AI was founded in 2018. |
| Where is Huma.AI headquartered? | Huma.AI is headquartered in Raleigh, NC, United States. |
| Is Huma.AI publicly listed? | No, Huma.AI is a private, VC-backed company. |
| What is Huma.AI's valuation? | Huma.AI was last valued at $1B in its seed round in September 2024. |
| How much funding has Huma.AI raised? | Huma.AI has raised $15M across 4 funding rounds. |
| What was Huma.AI's last funding round? | Huma.AI's last funding round was a $1M seed round in April 2025. |
| Who are Huma.AI's investors? | Huma.AI's investors include Fusion Fund, Excelerate Health Ventures, Boston Millennia Partners, Shangbay Capital, SteelSky Ventures, Human Longevity and Performance Impact Venture Fund, King Fund, W Fund and Hatteras Venture Partners. |
| Which companies are comparable to Huma.AI? | Companies comparable to Huma.AI include Claritev, Axtria, AgentSync, Wheel, Overjet and Vitec Software. |
See companies similar to Huma.AI
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




